Author Affiliation: Department of Obstetrics/Gynecology, Tufts University and New England Medical Center, Boston, Mass.
By the middle of the 20th century, it was well recognized that elderly
women frequently developed severe osteoporosis, resulting in a life complicated
by constant back pain and repeated fractures. By the 1970s and 1980s, it became
clear that use of estrogenic substances at or near the time of menopause could
prevent or treat osteoporosis, and these drugs became widely prescribed and
taken. Even before the bone-sparing effects of estrogen were known, these
agents were used extensively for the treatment of menopausal symptoms, primarily
vasomotor instability and vaginal atrophy.1
Noller KL. Estrogen Replacement Therapy and Risk of Ovarian Cancer. JAMA. 2002;288(3):368–369. doi:10.1001/jama.288.3.368
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: